Journal articles on the topic 'Fu ci'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Fu ci.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Methot, N., and K. Basler. "Suppressor of fused opposes hedgehog signal transduction by impeding nuclear accumulation of the activator form of Cubitus interruptus." Development 127, no. 18 (September 15, 2000): 4001–10. http://dx.doi.org/10.1242/dev.127.18.4001.
Full textZhou, Mengmeng, Yuhong Han, Bing Wang, Yong Suk Cho, and Jin Jiang. "Dose-dependent phosphorylation and activation of Hh pathway transcription factors." Life Science Alliance 5, no. 11 (September 5, 2022): e202201570. http://dx.doi.org/10.26508/lsa.202201570.
Full textKöhne, C.-H., J. Wils, M. Lorenz, P. Schöffski, R. Voigtmann, C. Bokemeyer, M. Lutz, et al. "Randomized Phase III Study of High-Dose Fluorouracil Given As a Weekly 24-Hour Infusion With or Without Leucovorin Versus Bolus Fluorouracil Plus Leucovorin in Advanced Colorectal Cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952." Journal of Clinical Oncology 21, no. 20 (October 15, 2003): 3721–28. http://dx.doi.org/10.1200/jco.2003.11.122.
Full textKabbinavar, Fairooz, Herbert I. Hurwitz, Louis Fehrenbacher, Neal J. Meropol, William F. Novotny, Grazyna Lieberman, Susan Griffing, and Emily Bergsland. "Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer." Journal of Clinical Oncology 21, no. 1 (January 1, 2003): 60–65. http://dx.doi.org/10.1200/jco.2003.10.066.
Full textKu, Geoffrey Yuyat, Benjamin Haaland, and Gilberto de Lima Lopes. "Cetuximab (C225) in the first-line treatment of advanced colorectal cancer (CRC) patients (Pts) with K-ras wild-type (WT) tumors: Does the choice and schedule of fluoropyrimidine (Fp) matter?" Journal of Clinical Oncology 30, no. 4_suppl (February 1, 2012): 576. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.576.
Full textWang-Gillam, Andrea, Chung-Pin Li, Gyorgy Bodoky, Andrew Dean, Yang-Shen Shan, Gayle S. Jameson, Teresa Macarulla, et al. "Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy." Journal of Clinical Oncology 34, no. 4_suppl (February 1, 2016): 417. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.417.
Full textWagner, Anna D., Wilfried Grothe, Johannes Haerting, Gerhard Kleber, Axel Grothey, and Wolfgang E. Fleig. "Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data." Journal of Clinical Oncology 24, no. 18 (June 20, 2006): 2903–9. http://dx.doi.org/10.1200/jco.2005.05.0245.
Full textArkenau, Hendrik-Tobias, Dirk Arnold, Jim Cassidy, Eduardo Diaz-Rubio, Jean-Yves Douillard, Howard Hochster, Andrea Martoni, et al. "Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials." Journal of Clinical Oncology 26, no. 36 (December 20, 2008): 5910–17. http://dx.doi.org/10.1200/jco.2008.16.7759.
Full textNam, Ki-Woong, Chi Kyung Kim, Tae Jung Kim, Kyungmi Oh, Moon-Ku Han, Sang-Bae Ko, and Byung-Woo Yoon. "FLAIR vascular hyperintensities predict early ischemic recurrence in TIA." Neurology 90, no. 9 (January 31, 2018): e738-e744. http://dx.doi.org/10.1212/wnl.0000000000005034.
Full textPoplin, Elizabeth A., Jacqueline K. Benedetti, Norman C. Estes, Daniel G. Haller, Robert J. Mayer, Richard M. Goldberg, Geoffrey R. Weiss, Saul E. Rivkin, and John S. Macdonald. "Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Continuous Infusion and Levamisole for Adjuvant Treatment of Stage III and High-Risk Stage II Colon Cancer." Journal of Clinical Oncology 23, no. 9 (March 20, 2005): 1819–25. http://dx.doi.org/10.1200/jco.2005.04.169.
Full textSisson, Barbara E., Suzanne L. Ziegenhorn, and Robert A. Holmgren. "Regulation of Ci and Su(fu) nuclear import in Drosophila." Developmental Biology 294, no. 1 (June 2006): 258–70. http://dx.doi.org/10.1016/j.ydbio.2006.02.050.
Full textSchilsky, Richard L., Jeremey Levin, William H. West, Alfred Wong, Bruce Colwell, Michael P. Thirlwell, Rafat H. Ansari, et al. "Randomized, Open-Label, Phase III Study of a 28-Day Oral Regimen of Eniluracil Plus Fluorouracil Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Therapy in Patients With Metastatic/Advanced Colorectal Cancer." Journal of Clinical Oncology 20, no. 6 (March 15, 2002): 1519–26. http://dx.doi.org/10.1200/jco.2002.20.6.1519.
Full textHoning, Judith, Justin Smit, Christina Muijs, Johannes Burgerhof, Jannet Beukema, John Theodorus Plukker, and Geke Hospers. "A comparison of carboplatin with paclitaxel and cisplatinum with 5-fluorouracil in definitive chemoradiotherapy in esophageal cancer patients." Journal of Clinical Oncology 32, no. 3_suppl (January 20, 2014): 104. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.104.
Full textSultana, Asma, Catrin Tudur Smith, David Cunningham, Naureen Starling, John P. Neoptolemos, and Paula Ghaneh. "Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer." Journal of Clinical Oncology 25, no. 18 (June 20, 2007): 2607–15. http://dx.doi.org/10.1200/jco.2006.09.2551.
Full textRao, Sheela, Francesco Sclafani, Cathy Eng, Richard A. Adams, Marianne G. Guren, David Sebag-Montefiore, Al Benson, et al. "International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct." Journal of Clinical Oncology 38, no. 22 (August 1, 2020): 2510–18. http://dx.doi.org/10.1200/jco.19.03266.
Full textSchmoll, Hans-Joachim, Josep Tabernero, Jean Alfred Maroun, Filippo G. De Braud, Timothy Jay Price, Eric Van Cutsem, Mark Hill, Silke Hoersch, Karen Rittweger, and Daniel G. Haller. "Capecitabine plus oxaliplatin (XELOX) versus bolus 5-fluorouracil/leucovorin (5-FU/LV) as adjuvant therapy for stage III colon cancer: Survival follow-up of study NO16968 (XELOXA)." Journal of Clinical Oncology 30, no. 4_suppl (February 1, 2012): 388. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.388.
Full textDouillard, Jean-Yves, Paulo M. Hoff, Jamey R. Skillings, Peter Eisenberg, Neville Davidson, Peter Harper, Mark D. Vincent, et al. "Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer." Journal of Clinical Oncology 20, no. 17 (September 1, 2002): 3605–16. http://dx.doi.org/10.1200/jco.2002.04.123.
Full textYang Seoung Duk. "A Study on the Ci-Fu Thoughts of Xie-Ling-Yun." Journal of Chinese Language and Literature ll, no. 54 (December 2009): 83–104. http://dx.doi.org/10.15792/clsyn..54.200912.83.
Full textYang, Seoung Duk. "A Study on The theory of Dong-Jin,s Ci-Fu." JOURNAL OF CHINESE HUMANITIES 76 (December 31, 2020): 223–43. http://dx.doi.org/10.35955/jch.2020.12.76.223.
Full textCassidy, J., N. Scotto, and E. Diaz-Rubio. "Review of completed and ongoing trials of capecitabine-based adjuvant therapy in patients with early-stage colon cancer." Journal of Clinical Oncology 29, no. 4_suppl (February 1, 2011): 495. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.495.
Full textMerchant, Mark, Felix F. Vajdos, Mark Ultsch, Henry R. Maun, Ulrich Wendt, Jennifer Cannon, William Desmarais, Robert A. Lazarus, Abraham M. de Vos, and Frederic J. de Sauvage. "Suppressor of Fused Regulates Gli Activity through a Dual Binding Mechanism." Molecular and Cellular Biology 24, no. 19 (October 1, 2004): 8627–41. http://dx.doi.org/10.1128/mcb.24.19.8627-8641.2004.
Full textMaisey, Nick, Ian Chau, David Cunningham, Andrew Norman, Matt Seymour, Tamas Hickish, Tim Iveson, et al. "Multicenter Randomized Phase III Trial Comparing Protracted Venous Infusion (PVI) Fluorouracil (5-FU) With PVI 5-FU Plus Mitomycin in Inoperable Pancreatic Cancer." Journal of Clinical Oncology 20, no. 14 (July 15, 2002): 3130–36. http://dx.doi.org/10.1200/jco.2002.09.029.
Full textBertagnolli, Monica M., Donna Niedzwiecki, Carolyn C. Compton, Hejin P. Hahn, Margaret Hall, Beatrice Damas, Scott D. Jewell, et al. "Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803." Journal of Clinical Oncology 27, no. 11 (April 10, 2009): 1814–21. http://dx.doi.org/10.1200/jco.2008.18.2071.
Full textWang-Gillam, Andrea, Richard Hubner, Beloo Mirakhur, Floris A. de Jong, Bruce Belanger, and Li-Tzong Chen. "Dose modifications of liposomal irinotecan (nal-IRI) + 5-fluorouracil/leucovorin (5-FU/LV) in NAPOLI-1: Impact on efficacy." Journal of Clinical Oncology 36, no. 4_suppl (February 1, 2018): 388. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.388.
Full textTaïeb, Julien, Tim Maughan, Carsten Bokemeyer, Eric Van Cutsem, Thomas Brodowicz, Gunnar Folprecht, Regina Esser, Michael Schlichting, and Josep Tabernero. "Cetuximab combined with infusional 5-fluorouracil/folinic acid (5-FU/FA) and oxaliplatin in metastatic colorectal cancer (mCRC): A pooled analysis of COIN and OPUS study data." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 3574. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.3574.
Full textWagner, A. D., W. Grothe, J. Haerting, G. Kleber, A. Grothey, and W. E. Fleig. "Combination chemotherapies in advanced gastric cancer: An updated systematic review and meta-analysis." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 4555. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4555.
Full textSchmoll, Hans-Joachim, Josep Tabernero, Jean Maroun, Filippo de Braud, Timothy Price, Eric Van Cutsem, Mark Hill, Silke Hoersch, Karen Rittweger, and Daniel G. Haller. "Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial." Journal of Clinical Oncology 33, no. 32 (November 10, 2015): 3733–40. http://dx.doi.org/10.1200/jco.2015.60.9107.
Full textSizer, B., A. Makris, C. Barone, P. Mainwaring, and P. Eggleton. "QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 3631. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.3631.
Full textKöhne, C. H., E. van Cutsem, J. Wils, C. Bokemeyer, M. El-Serafi, M. P. Lutz, M. Lorenz, et al. "Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986." Journal of Clinical Oncology 23, no. 22 (August 1, 2005): 4856–65. http://dx.doi.org/10.1200/jco.2005.05.546.
Full textPeng, Chengwei, Saad Saffo, Michael Shusterman, Daniel Jacob Becker, Jordan Berlin, Paul Eliezer Oberstein, Anil Nagar, and Shun Yu. "Analysis of the impact of eliminating bolus 5-fluorouracil in metastatic colorectal cancer." Journal of Clinical Oncology 41, no. 4_suppl (February 1, 2023): 59. http://dx.doi.org/10.1200/jco.2023.41.4_suppl.59.
Full textFuchs, Charles S., Donna Niedzwiecki, Harvey J. Mamon, Joel E. Tepper, Xing Ye, Richard S. Swanson, Peter C. Enzinger, et al. "Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)." Journal of Clinical Oncology 35, no. 32 (November 10, 2017): 3671–77. http://dx.doi.org/10.1200/jco.2017.74.2130.
Full textLi, Jia-yi, Xuan-zhang Huang, Peng Gao, Xiao-wan Chen, Yong-xi Song, Xing-er Lv, Yv Fu, Qiong Xiao, and Zhen-ning Wang. "Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment." BioMed Research International 2021 (March 27, 2021): 1–21. http://dx.doi.org/10.1155/2021/8852699.
Full textWang, Aiqing. "Cliché-ridden Online Danmei Fiction? A Case Study of Tianguan ci fu." Acta Asiatica Varsoviensia 35 (2022): 281–314. http://dx.doi.org/10.60018/acasva.iray5065.
Full textSchmidt, Jan, Ulrich Abel, Jürgen Debus, Sabine Harig, Katrin Hoffmann, Thomas Herrmann, Detlef Bartsch, et al. "Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma." Journal of Clinical Oncology 30, no. 33 (November 20, 2012): 4077–83. http://dx.doi.org/10.1200/jco.2011.38.2960.
Full textModest, Dominik Paul, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Lothar Müller, Alexander Koenig, Ludwig Fischer von Weikersthal, et al. "FU/FA maintenance therapy with or without panitumumab (pmab) in RAS wild-type metastatic colorectal cancer (mCRC) (PanaMa, AIO KRK 0212): Updated efficacy analyses." Journal of Clinical Oncology 42, no. 16_suppl (June 1, 2024): 3506. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3506.
Full textYothers, Greg, Patricia A. Ganz, Samia H. Lopa, Clifford Y. Ko, D. Lawrence Wickerham, and Norman Wolmark. "Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04." Journal of Clinical Oncology 30, no. 4_suppl (February 1, 2012): 391. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.391.
Full textSargent, Daniel J., Silvia Marsoni, Genevieve Monges, Stephen N. Thibodeau, Roberto Labianca, Stanley R. Hamilton, Amy J. French, et al. "Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer." Journal of Clinical Oncology 28, no. 20 (July 10, 2010): 3219–26. http://dx.doi.org/10.1200/jco.2009.27.1825.
Full textLiu, Guo-Chen, Jun-Ping Yan, Qing He, Xin An, Zhi-Zhong Pan, and Pei-Rong Ding. "Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis." Gastroenterology Research and Practice 2016 (2016): 1–10. http://dx.doi.org/10.1155/2016/1798285.
Full textFreeman, Karoline, Martin Connock, Ewen Cummins, Tara Gurung, Sian Taylor-Phillips, Rachel Court, Mark Saunders, Aileen Clarke, and Paul Sutcliffe. "Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion." Health Technology Assessment 19, no. 91 (November 2015): 1–322. http://dx.doi.org/10.3310/hta19910.
Full textZafar, Amna, Zsofia D. Drobni, Matthew Lei, Carlos A. Gongora, Thiago Quinaglia, Uvette Y. Lou, Ramya Mosarla, et al. "The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm." PLOS ONE 17, no. 4 (April 7, 2022): e0265767. http://dx.doi.org/10.1371/journal.pone.0265767.
Full textIkawati, Muthi, and Endah Puji Septisetyani. "Pentagamavunone-0 (PGV-0), a Curcumin Analog, Enhances Cytotoxicity of 5-Fluorouracil and Modulates Cell Cycle in WiDr Colon Cancer Cells." Indonesian Journal of Cancer Chemoprevention 9, no. 1 (February 28, 2018): 23. http://dx.doi.org/10.14499/indonesianjcanchemoprev9iss1pp23-31.
Full textSholihah, Imroatus, Meirizky Zulharini S., Amalia Miranda, Refki Riswansyah, and Riris Istighfari Jenie. "Jure Leaf Extract (Nerium indium Mill.) Increased 5-Fluorouracil Sensitivity through Inhibition of NF-κB Activation and Transporter Protein in WiDr Colon Cancer Cell." Indonesian Journal of Cancer Chemoprevention 7, no. 3 (February 1, 2017): 87. http://dx.doi.org/10.14499/indonesianjcanchemoprev7iss3pp87-92.
Full textAl-Thani, Hassan, Ayman El-Menyar, Valsa Koshy, Ahmed Hussein, Ahmed Sharaf, Mohammad Asim, and Ahmed Sadek. "Implications of Foot Ulceration in Hemodialysis Patients: A 5-Year Observational Study." Journal of Diabetes Research 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/945075.
Full textMohamed, Yehia I., Aliya Qayyum, Manal Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia, Sunyoung S. Lee, et al. "Treatment outcome and prognostic indicators in 26 cases of fibrolamellar hepatocellular carcinoma under interferon based therapy." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e16626-e16626. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16626.
Full textHaller, Daniel G., Josep Tabernero, Jean Maroun, Filippo de Braud, Timothy Price, Eric Van Cutsem, Mark Hill, Frank Gilberg, Karen Rittweger, and Hans-Joachim Schmoll. "Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer." Journal of Clinical Oncology 29, no. 11 (April 10, 2011): 1465–71. http://dx.doi.org/10.1200/jco.2010.33.6297.
Full textBang, Kyunghye, Jaekyung Cheon, Jae Ho Jeong, Hyeon-Su Im, Kyu-Pyo Kim, Baek-Yeol Ryoo, and Changhoon Yoo. "Efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin after progression on conventional irinotecan-containing chemotherapy for metastatic pancreatic adenocarcinoma." Journal of Clinical Oncology 39, no. 3_suppl (January 20, 2021): 382. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.382.
Full textBang, Kyunghye, Jaekyung Cheon, Jae Ho Jeong, Hyeon-Su Im, Kyu-pyo Kim, Baek-Yeol Ryoo, and Changhoon Yoo. "Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy." Therapeutic Advances in Medical Oncology 13 (January 2021): 175883592110030. http://dx.doi.org/10.1177/17588359211003053.
Full textMcCaffrey, J. A., S. Hilton, M. Mazumdar, S. Sadan, M. Heineman, J. Hirsch, W. K. Kelly, H. I. Scher, and D. F. Bajorin. "Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma." Journal of Clinical Oncology 15, no. 6 (June 1997): 2449–55. http://dx.doi.org/10.1200/jco.1997.15.6.2449.
Full textTesta, Luca, Azeem Latib, Nedy Brambilla, Federico De Marco, Claudia Fiorina, Marianna Adamo, Cristina Giannini, et al. "Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis." European Heart Journal 41, no. 20 (January 6, 2020): 1876–86. http://dx.doi.org/10.1093/eurheartj/ehz925.
Full textHendlisz, Alain, Marc Van den Eynde, Marc Peeters, Geert Maleux, Bieke Lambert, Jaarke Vannoote, Katrien De Keukeleire, et al. "Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy." Journal of Clinical Oncology 28, no. 23 (August 10, 2010): 3687–94. http://dx.doi.org/10.1200/jco.2010.28.5643.
Full text